Translocation involving chromosome 22 in Ewing's Sarcoma. A cytogenetic study of four fresh tumors

https://doi.org/10.1016/0165-4608(84)90003-7Get rights and content

Abstract

Ewing's sarcoma was described in 1921 by James Ewing as a diffuse endothelioma of bone and, for some time, was believed to be an undifferenciated type of Parker's sarcoma. At present, these two entities are thought to be distinct, the macroscopic and microscopic aspects of Ewing's sarcoma being very characteristic, although the exact cell type of this tumor remains unknown. This has lead many workers to study this sarcoma in order to recognize its origin.

We thought it of interest to carry out cytogenetic investigations of our cases of Ewing's sarcoma, since very few chromosomal data on this malignancy exist in the literature [1–3].

References (9)

There are more references available in the full text version of this article.

Cited by (186)

  • Molecular aspects of Ewing’s sarcomas

    2021, Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
  • Soft Tissue Sarcomas and Mesenchymal Neoplasms of Uncertain Histogenesis With Characteristic Translocations

    2019, Practical Soft Tissue Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series
  • Molecular assessment of circulating exosomes toward liquid biopsy diagnosis of Ewing sarcoma family of tumors

    2018, Translational Research
    Citation Excerpt :

    This recipient gene encodes for a multifunctional protein that is involved in various cellular processes, including gene expression, cell signaling, and RNA processing and transport. In approximately 90% of these lesions, the disease-associated genomic alteration is a translocation between the long arms of chromosomes 11 and 22 (t[11;22] [q24;q12]).25-27 Upon cloning of the specific breakpoints, it was shown to involve the EWS gene (EWSR1) on chromosome 22 and the FLI1 gene on chromosome 11.

  • Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    2018, Annals of Oncology
    Citation Excerpt :

    Molecular biology studies have shown that almost all of these tumours share a common TET-ETS gene rearrangement involving the EWSR1 gene on chromosome 22 [61–64]. In most cases, this involves a reciprocal translocation t(11; 22)(q24; q12) [47], but t(21; 22)(q22; q12), and others may also occur [t(7; 22), t(17; 22) and t(2; 22)] [61–64]. In recent years, new small round cell sarcoma entities have been recognised, with novel translocations, among which BCL6 corepressor (BCOR)-rearranged sarcoma preferentially affects the bone.

  • Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application

    2023, Journal of Cancer Research and Clinical Oncology
View all citing articles on Scopus

This work was supported by grants from CNRS (ERA 47 and ER 264) and Electricité de France.

View full text